Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
Sonja Lang, Bernd Schnabl
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 233-244
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 291
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 286
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Yana Geng, Klaas Nico Faber, Vincent E. de Meijer, et al.
Hepatology International (2021) Vol. 15, Iss. 1, pp. 21-35
Open Access | Times Cited: 243
The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 196
Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence, Morris J. Birnbaum
Molecular Metabolism (2020) Vol. 50, pp. 101143-101143
Open Access | Times Cited: 153
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 143
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 411-438
Open Access | Times Cited: 134
The fecal mycobiome in non-alcoholic fatty liver disease
Münevver Demir, Sonja Lang, Phillipp Hartmann, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 788-799
Open Access | Times Cited: 119
Gut Microbiota Participates in Polystyrene Microplastics-Induced Hepatic Injuries by Modulating the Gut–Liver Axis
Kai-Kai Zhang, Jian-Zheng Yang, Lijian Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 15125-15145
Closed Access | Times Cited: 76
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease
Marija Dukić, Tijana Radonjić, Igor Jovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3735-3735
Open Access | Times Cited: 63
Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae
Lin Gan, Yanling Feng, Bing Du, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 46
Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 44
Chronic arsenic exposure-provoked biotoxicity involved in liver-microbiota-gut axis disruption in chickens based on multi-omics technologies
Jiayi Li, Changming Guo, Yan Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 16
Modulating the microbiome in chronic liver diseases- current evidence on the role of fecal microbiota transplantation
Srishti Saha, Bernd Schnabl
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 87
Diagnosis and management of secondary causes of steatohepatitis
Roman Liebe, Iréne Esposito, Hans H. Bock, et al.
Journal of Hepatology (2021) Vol. 74, Iss. 6, pp. 1455-1471
Open Access | Times Cited: 84
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Youngmin A. Lee, Scott L. Friedman
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 11-31
Open Access | Times Cited: 68
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 64
Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
Patrick A. de Jonge, Koen Wortelboer, Torsten P. M. Scheithauer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 61
Potato resistant starch inhibits diet-induced obesity by modifying the composition of intestinal microbiota and their metabolites in obese mice
Dan Liang, Liang Zhang, Hongzhu Chen, et al.
International Journal of Biological Macromolecules (2021) Vol. 180, pp. 458-469
Closed Access | Times Cited: 59
Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation
Wenbing Hu, Wenyu Gao, Zongmin Liu, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2945-2945
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top